The Preventing Illegal Laboratories and Protecting Public Health Act of 2026 aims to enhance the regulation of highly pathogenic agents, which are biological materials that pose significant health risks. The primary goal is to ensure that distributors maintain accurate records of their transactions to improve public health safety and prevent misuse of these dangerous materials. To achieve this, the legislation requires all distributors of highly pathogenic agents to keep a detailed electronic logbook.